Results 111 to 120 of about 6,333 (188)

Microsimulation model

Report of a microsimulation model to perform effectiveness and cost effectiveness analyses.
openaire   +1 more source

Development of Disordered Weight Control Behaviors and Its Progression to Eating Disorders in Canada: A Nationally Representative Microsimulation. [PDF]

Int J Eat Disord
Shen Y, Beccia AL, Menzies NA, Gao C, Austin SB, Raffoul A.   +5 more
europepmc   +1 more source

Demographic Change and the Future of Austria's Long-Term-Care Allowance: A Dynamic Microsimulation Study. [PDF]

Healthcare (Basel)
Famira-Mühlberger U, Horvath T, Leoni T, Spielauer M, Szenkurök V, Warum P.   +5 more
europepmc   +1 more source

Productivity-adjusted life year loss among the late middle-aged adults in China. [PDF]

Commun Med (Lond)
Jiang Y, Hu B, Gu H, Hu W, Jiang S, Gu Y, Si L.   +6 more
europepmc   +1 more source

The quality-of-life impacts and economic burden of X-linked retinitis pigmentosa caused by variants in RPGR. [PDF]

Eye (Lond)
Schofield D, Kraindler J, Shrestha RN, Tan O, West S, Hart N, Wall L, Tan L, Hewett D, Villaret L, Ma A, Grigg JR, Jamieson RV.   +12 more
europepmc   +1 more source

Microsimulation reveals that medically assisted reproduction is unlikely to compensate for cohort fertility decline due to increasing maternal ages. [PDF]

Hum Reprod
Granholm R, Cantineau AEP, Hoek A, Stulp G.   +3 more
europepmc   +1 more source

Machine learning for personalized antimicrobial susceptibility breakpoints. [PDF]

J Antimicrob Chemother
Zhong Y, Hope W, Buchan I, Velluva A, Gerada A, Rosato C, Green PL, Howard A.   +7 more
europepmc   +1 more source

The Cost Effectiveness of Upgrading Cochlear Implant Sound Processors in Australia: A Novel Application of Individual-Level Microsimulation Models. [PDF]

Pharmacoeconomics
Parkinson B, Seil E, Sharma R, Incerti P, Gavrilis J, Ahumada-Canale A, Kitterick P.   +6 more
europepmc   +1 more source

Development, Testing, and Calibration of LINCS: A New Microsimulation Model of Maternal and Fetal Cytomegalovirus Infection in the United States. [PDF]

MDM Policy Pract
Wu AS, Coskun E, Prabhu M, Santos EM, Kakkar F, Flanagan CF, Dugdale CM, Pesch M, Ciaranello AL, Giardina JC.   +9 more
europepmc   +1 more source

Modelled CKD Benefits of Broad Sodium-Glucose Cotransporter-2 Inhibitor Eligibility in the UK. [PDF]

Kidney Int Rep
Tangri N, Priest S, Zara A, Long BR, Rao N, Froguel CE, Adshead F, Chadban S.   +7 more
europepmc   +1 more source